– World leader in research and clinical treatment of age-related cognitive and functional decline to maximize human performance, Aviv Scientific, announced the closing of a oversubscribed Series B funding round.
– Led by Israel’s largest public medical services conglomerate, Danel LTD; Jeff Horing’s Deep Insight Fund; the country’s most successful high-tech angels and entrepreneurs; international longevity and healthspan optimization focused investors; the Series B fundraise will accelerate the global rollout of its network of medical clinics and the development of the Aviv Aging Database.
– The application marked the first-time scientists successfully managed to biologically reverse the aging process in healthy humans, using hyperbaric oxygen therapy to lengthen telomeres and reduce senescent cells while also demonstrating cognitive enhancement in healthy adults.